GLENMARK PHARM 1D: Investment strategy explained in chart

Zaktualizowano
GLEANMARK PHARM seems to be find out the bottom as suggested by Elliott waves. Also exhaustion gap and breakaway gaps found along with divergence in price and RSI. Good for investment (long) for both short and long terms.
CMP: ₹301
Target: Short term 1 year: ₹600
Long term 5 years: ₹1200
Uwaga
In this case RSI is used only fire divergence purpose
Uwaga
Today it registered 15% high
Uwaga
Today Closed at 366. A gain of 65 points or 21.50%
Chart PatternsWave Analysis

Wyłączenie odpowiedzialności